Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on March 28, 2025

Transforming Wellness: Abundant Health Introduces RENEW Protocols for Lasting Relief
Davenport, Iowa, March 28, 2025 (GLOBE NEWSWIRE) -- Abundant Health Physical Medicine, a leading integrative wellness clinic in the Midwest, is transforming the treatment of neuropathy, chronic joint pain, autoimmune conditions, and spinal health through …

Zefiro Methane Corp. Engages TÜV SÜD to Validate and Verify its ACRcarbon Listed Projects
FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced that it has engaged TÜV SÜD America (“TÜV SÜD”), a technical inspection …

China Asset Management Wins Two ESG Honors from the 2024 Global Brand Frontier Awards by Boston Brand Research & Media
ChinaAMC wins Best Asset Manager …

Trump vigorously promotes cryptocurrency, Savvy cloud mining promotes global financial innovation
Bishop Auckland, UK, March 28, 2025 (GLOBE NEWSWIRE) -- In response to Trump's comments on the rapid growth of the cryptocurrency market and people's growing interest in blockchain technology, SAVVY MINING has launched a series of new cloud mining plans to …

Helport AI to Host First Half Fiscal Year 2025 Financial Results Conference Call on Monday, March 31, 2025 at 4:30 p.m. Eastern Time
SINGAPORE and SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), an AI technology company serving enterprise clients with intelligent customer communication software and services, will hold a …

Live Ventures CEO Announces Purchase of 55,796 Shares of the Company’s Common Stock in the Open Market
LAS VEGAS, March 28, 2025 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures” or the “Company”), a diversified holding company, today announced that Jon Isaac, its President and Chief Executive Officer, acquired 55,796 shares of …

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial results for the fiscal year ended December 31, 2024, …

Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on Recent Groundbreaking Preclinical Data
Grand Cayman, Cayman Islands, March 28, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today …

Coherent Announces General Availability of 800G ZR/ZR+ QSFP-DD Transceiver
SAXONBURG, Pa., March 28, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announces general availability of its 800G ZR/ZR+ transceiver in QSFP-DD form factor. This launch reinforces the company’s commitment to next- …

NANO Nuclear Energy Bolsters the Engineering Team Overseeing the Development of its ODIN™ Microreactor with Three Additional Leading Professionals
New York, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that three …

Neurostimulation Devices Market Set to Reach US$ 11.83 Billion by 2030, Driven by Rising Neurological Disorders and Technological Advancements - The Insight Partners
US …

Aptose Reports Year End 2024 Results and Corporate Highlights
Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third Drug to Include in AML Triplet Therapy Aptose Signs Debt Conversion Agreement with Hanmi SAN DIEGO and TORONTO, March 28, …

Tr1X Announces Succession Plan: Appoints David de Vries CEO, Effective June 1; Bill Lis to Serve as Executive Chairman
SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies with the potential to cure autoimmune and inflammatory …

GlobalTech Corporation Announces Fourth Quarter and Year End 2024 Results
RENO, Nev., March 28, 2025 (GLOBE NEWSWIRE) -- GlobalTech Corporation (GTC, OTC:GTLK) (“GlobalTech” or the “Company”), a leading U.S.-based technology investment holding company, today announced financial results for the year ending December 31, 2024. Full …

Actelis Receives Significant New Orders to Modernize U.S. Military Bases with Rapid Deployment, Cyber Hardened Networking
FREMONT, Calif., March 28, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced it has …

Tide Capital Sees Bitcoin Entering Strategic Buy Zone Amid Macro Turbulence
New York, NY, March 28, 2025 (GLOBE NEWSWIRE) -- Bitcoin’s recent price retreat has created a strategic entry point, according to Tide Capital, as recession risks and institutional dynamics signal a potential market bottom. Despite macroeconomic headwinds, …

Vicon’s new markerless system enabling Dreamscape Immersive’s latest VR experience
28 March 2025 Oxford Metrics plc ("Oxford Metrics" or the “Group”) Vicon’s new markerless system enabling Dreamscape Immersive’s latest VR experience New location-based VR technology to launch at Dreamscape’s Geneva flagship store in partnership with Swiss …

Mining Remanufacturing Components Market Size Worth $5.94 Billion, Globally, by 2030 Growing at 4.4% CAGR | Exclusive Report by The Insight Partners
US …

Lexicon Pharmaceuticals Announces Exclusive License Agreement with Novo Nordisk for LX9851
THE WOODLANDS, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has entered into an exclusive license agreement with Novo Nordisk A/S for LX9851, a first-in-class, oral non-incretin development …

LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Focused on the evaluation of strategic alternatives Adopted a restructuring plan to extend capital resources, incurring a reduction in workforce of 30% to support the evaluation of strategic options and the Phase 1 study for LAVA-1266 Phase 1 enrollment in …